However, the roles of CRC protein biomarkers for diagnosis, therapy and prognosis can be overlapped with multiple functions, such as TP53 in CRC therapy and prognosis [17,18,19], Ras [20], BCL2 [21], CD44 [22], CEA [23] in CRC prognosis. This evidence concerns the gene TP53 and colorectal carcinoma.